A cross-sectional study examining the psychometric properties of the painDETECT measure in neuropathic pain

被引:26
作者
Cappelleri, Joseph C. [1 ]
Koduru, Vijaya [2 ]
Bienen, E. Jay [3 ]
Sadosky, Alesia [4 ]
机构
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Eliassen Grp, New London, CT USA
[3] Outcomes Res Consultant, New York, NY USA
[4] Pfizer Inc, New York, NY 10017 USA
来源
JOURNAL OF PAIN RESEARCH | 2015年 / 8卷
关键词
painful diabetic neuropathy; spinal cord injury; back pain; small fiber neuropathy; HIV-related peripheral neuropathy; posttrauma neuropathy; ADULTS SEEKING TREATMENT; UNITED-STATES; PERIPHERAL NEUROPATHY; BURDEN; GUIDELINES;
D O I
10.2147/JPR.S80046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Similarities and differences on the nine-item and seven-item versions of painDETECT, a patient-reported screener to identify neuropathic pain (NeP), have not been psychometrically explored across NeP conditions. Methods: Scores on the nine-item painDETECT (seven pain symptom items, one pain course pattern item, one pain radiation item) range from -1 to 38; scores >= 19 indicate NeP is likely (>90% probability). The seven-item version (only pain symptoms) score range is 0 to 35. -painDETECT was administered to subjects with confirmed diagnoses of human immunodeficiency virus-related peripheral NeP (HIVP) (n=103), spinal cord injury-related NeP (SCI) (n=103), small fiber neuropathy (n=100), painful diabetic peripheral neuropathy (n=112), posttrauma/-postsurgical NeP (n=100), and NeP in chronic low back pain (n=106) identified during office visits to US community-based physicians. Analysis of covariance compared mean scores (adjusted for age, sex, race, ethnicity, time since NeP diagnosis, and number of comorbidities) on the nine-item and seven-item versions of painDETECT. Cronbach's alpha assessed internal consistency reliability, and corrected item-to-total correlations assessed item-level discrimination. Results: The adjusted mean nine-item scores ranged from 21.0 (SCI) to 24.3 (small fiber -neuropathy). Differences between conditions were either trivial or small-to-medium in magnitude. Cronbach's alpha gave overall internal consistency reliability of 0.76, with a range of 0.63 (SCI) to 0.82 (HIVP). Mean scores and Cronbach's alphas for the seven-item version were generally similar to the nine-item version. Corrected item-to-total correlations adequately discriminated all pain symptom items on both painDETECT versions for each condition (0.3-0.7), but the two nonsensory items on the nine-item version showed lackluster discrimination (<0.3). Conclusion: painDETECT scores were within the range indicating high probability of NeP. -Differences between conditions were generally modest or not large. Both versions showed evidence of internal consistency reliability and item-level discrimination, suggesting that painDETECT is a useful screening measure for identifying NeP across NeP conditions.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 28 条
  • [1] EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
    Attal, N.
    Cruccu, G.
    Baron, R.
    Haanpaa, M.
    Hansson, P.
    Jensen, T. S.
    Nurmikko, T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) : 1113 - E88
  • [2] Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach
    Baron, Ralf
    Foerster, Matti
    Binder, Andreas
    [J]. LANCET NEUROLOGY, 2012, 11 (11) : 999 - 1005
  • [3] A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms
    Baron, Ralf
    Toelle, Thomas R.
    Gockel, Ulrich
    Brosz, Mathias
    Freynhagen, Rainer
    [J]. PAIN, 2009, 146 (1-2) : 34 - 40
  • [4] Using screening tools to identify neuropathic pain
    Bennett, Michael I.
    Attal, Nadine
    Backonja, Miroslav M.
    Baron, Ralf
    Bouhassira, Didier
    Freynhagen, Rainer
    Scholz, Joachim
    Toelle, Thomas R.
    Wittchen, Hans-Ulrich
    Jensen, Troels Staehelin
    [J]. PAIN, 2007, 127 (03) : 199 - 203
  • [5] Cappelleri JC, 2014, CH CRC BIOSTAT SER, P1
  • [6] Measurement properties of painDETECT by average pain severity
    Cappelleri, Joseph C.
    Bienen, E. Jay
    Koduru, Vijaya
    Sadosky, Alesia
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 497 - 504
  • [7] Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
  • [8] Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
  • [9] Cultural Adaptation and Validation of the painDETECT Scale Into Spanish
    De Andres, Jose
    Perez-Cajaraville, Juan
    Dolores Lopez-Alarcon, Maria
    Manuel Lopez-Millan, Jose
    Margarit, Cesar
    Dolores Rodrigo-Royo, Maria
    Luisa Franco-Gay, Maria
    Abejon, David
    Angel Ruiz, Miguel
    Lopez-Gomez, Vanessa
    Perez, Maria
    [J]. CLINICAL JOURNAL OF PAIN, 2012, 28 (03) : 243 - 253
  • [10] Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
    Dworkin, Robert H.
    O'Connor, Alec B.
    Audette, Joseph
    Baron, Ralf
    Gourlay, Geoffrey K.
    Haanpaa, Maija L.
    Kent, Joel L.
    Krane, Elliot J.
    LeBel, Alyssa A.
    Levy, Robert M.
    Mackey, Sean C.
    Mayer, John
    Miaskowski, Christine
    Raja, Srinivasa N.
    Rice, Andrew S. C.
    Schmader, Kenneth E.
    Stacey, Brett
    Stanos, Steven
    Treede, Rolf-Detlef
    Turk, Dennis C.
    Walco, Gary A.
    Wells, Christopher D.
    [J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (03) : S3 - S14